Bridge the Gap (BTG) - Black Youth Group
ConditionSuicide Prevention
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-17
SponsorChildren's Hospital Los Angeles
About this trial
The goal of this clinical trial is to develop and preliminarily test a culturally adapted suicide intervention specifically for black youth. The main question it aims to answer:
-To evaluate the feasibility and acceptability of the group, as well as the preliminary efficacy of the group for decreasing suicidal thoughts and behaviors and increasing protective factors such as hope, positive ethnic identity, and family and peer support.
Participants will be asked to attend 10-week group intervention and complete pre-treatment and post-treatment assessment measures.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
12-17 years old
Identify as Black or African American or being of African descent
Have current suicidal ideation or suicidal ideation within the last 30 days
Have assent from the adolescent participant and consent from an individual's caregiver or guardian to participate.
Disqualifiers
An active psychotic disorder or current psychosis symptoms
No history of suicide attempt(s) or suicide ideation in the past 30 days
Cognitive deficits or a medical condition diagnosed from a medical provider that precludes full understanding of study materials as assessed through an inability to complete the pre-treatment CAMS SSF & SSP
Caregivers, guardians, and/or the patient refuse to participate.
Trial design
Design model
Single group
Treatments tested in this trial
Bridge the Gap (BTG) - Black Youth Group
BehavioralParticipants will complete a group intervention, rooted in the Collaborative Assessment \& Management of Suicidality (CAMS) evidence-based model, driven by their own unique identification of suicide drivers.
Treatment groups
16 Participants
are divided into 1 treatment groupGroup A: Treatment ArmExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
The Collaborative Assessment & Management of Suicidality - Suicide Status Form (SSF)
An assessment of suicide risk that consists of six core assessment constructs: psychological pain, stress, agitation, hopelessness, self-hate, and overall risk of suicide; as well as reasons for living and reasons for dying constructs, and wish to live and wish to die constructs.
Time frame
From pre-treatment until 3 months post-treatment, approximately 23 weeks.2
Ethnic Identity Scale (EIS)
A 17-item scale that assesses the three components of ethnic identity and distinguishes between exploration, resolution, and affirmation. Scores range from 17-68, with higher scores indicating higher levels of affirmation, exploration, and resolution.
Time frame
From baseline until 3 months post-treatment, approximately 22 weeks.3
Living Ladder Scale
A one-item measure that is prospectively associated with suicidal ideation and suicide attempts by measuring readiness to continue living among individuals thinking of suicide. Scores range from 0-8, with 8 indicating an individual is committed to making changes to make their lives worth living.
Time frame
From baseline until 3 months post-treatment, approximately 22 weeks.4
Brief Suicide Cognitions Scale (B-SCS)
A 6-item self-report scale that measures the suicidal belief system, including dimensions of unlovability, unbearability, and unsolvability. Scores range from 6-30, with lower scores indicating fewer suicide cognitions.
Time frame
From baseline until 3 months post-treatment, approximately 22 weeks.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Children's Hospital Los Angeles
Lead sponsor
American Psychological Foundation
Collaborator
Source ClinicalTrials.gov